Santhera Pharmaceuticals hits the market with Sfr77m capital raising
Santhera Pharmaceuticals, the Swiss speciality pharmaceuticals company, has launched a Sfr77m fundraising following the release of its latest earnings statement on Wednesday morning.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: